Related Experiment Video
Updated: Aug 16, 2026
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Viruses for the treatment of malignant glioma
1Department of Microbiology, Duke University Medical Center, Durham, NC 27710, USA. grome001@mc.duke.edu
Abstract:
Viruses have been considered for use as therapeutic agents against cancer, and malignant glioma in particular. Oncolytic viruses were designed to target malignant cells supporting efficient virus replication, or rendered vulnerable to viral destruction due to tumor-specific defects in their defense against virus infection. Other than conventional cancer chemotherapy, viral antineoplastic agents require complex interactions with the host organism to reach their target and to unleash their oncolytic activity. Recent progress in the design and therapeutic application of oncolytic viruses carries the promise to make these agents available for treatment of malignant glioma.
Insights
Oncolytic viruses are engineered to target and destroy cancer cells, particularly malignant glioma. Advances in their design offer a promising new avenue for cancer therapy beyond traditional chemotherapy.
Area of Science:
- Virology
- Oncology
- Cancer Therapeutics
Background:
- Malignant glioma is a challenging cancer with limited treatment options.
- Viruses are being explored as novel therapeutic agents for cancer treatment.
- Oncolytic viruses selectively infect and replicate within tumor cells.
Purpose of the Study:
- To review the therapeutic potential of oncolytic viruses for malignant glioma.
- To discuss the mechanisms of oncolytic virus action against cancer cells.
- To highlight recent advancements in oncolytic virus design and application.
Main Methods:
- Review of existing literature on oncolytic virotherapy for glioma.
- Analysis of viral targeting strategies for malignant cells.
- Examination of host-virus interactions in the context of cancer therapy.
Main Results:
- Oncolytic viruses demonstrate selective replication in tumor cells.
- Tumor-specific defects enhance cancer cell vulnerability to viral infection.
- Viral antineoplastic agents require complex host interactions for efficacy.
Conclusions:
- Oncolytic viruses show significant promise as a novel treatment for malignant glioma.
- Further research and development in oncolytic virus design are crucial.
- These agents represent a potential paradigm shift in cancer chemotherapy.
More Related Videos
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
09:33Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy